You have 9 free searches left this month | for more free features.

ace inhibitors

Showing 1 - 25 of 4,928

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)

Recruiting
  • Breast Feeding
  • +3 more
  • Venipuncture
  • Leuven, Vlaams-Brabant, Belgium
    Universitaire Ziekenhuizen Leuven
Oct 12, 2023

Hypertension, Aging, Sedentary Lifestyle Trial in Birmingham, Aurora, Orlando (Aerobic exercise, Perindopril, Losartan)

Recruiting
  • Hypertension
  • +2 more
  • Aerobic exercise
  • +3 more
  • Birmingham, Alabama
  • +2 more
May 6, 2022

Influenza Vaccination, ACEI and ARB in Evolution of SARS-Covid19

Recruiting
  • COVID19
  • +3 more
  • Terrassa, Barcelona, Spain
    Hospital de Terrassa
Mar 9, 2022

SARS-CoV-2, COVID-19 Trial in Austria, Germany (ACE inhibitor, angiotensin receptor blocker)

Completed
  • SARS-CoV-2
  • COVID-19
  • ACE inhibitor, angiotensin receptor blocker
  • Innsbruck, Tyrol, Austria
  • +30 more
Aug 18, 2022

Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors

Not yet recruiting
  • Aortic Valve Stenosis
  • Angiotensin Receptor-Neprilysin Inhibitor
  • antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 4, 2023

Heart Failure Trial in Tel Aviv (ACE inhibitors, beta blockers)

Recruiting
  • Heart Failure
  • ACE inhibitors
  • beta blockers
  • Tel Aviv, Israel
    Tel Aviv Medical Center
Feb 1, 2022

Breast Cancer, Cardiotoxicity Trial in Florence (Bisoprolol, Ramipril, Placebo)

Active, not recruiting
  • Breast Cancer
  • Cardiotoxicity
  • Florence, Italy
    Azienda Ospedaliero-Universitaria Careggi, Florence University
Jan 16, 2022

Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,

Recruiting
  • Disease Free Survival
  • +2 more
  • use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
  • Milan, Italy
    IRCCS San Raffaele
Mar 7, 2022

Hypertension in Pregnancy, Postpartum Preeclampsia Trial in Houston (ACE Inhibitors and Diuretics, NIFEdipine ER)

Recruiting
  • Hypertension in Pregnancy
  • Postpartum Preeclampsia
  • ACE Inhibitors and Diuretics
  • NIFEdipine ER
  • Houston, Texas
    University of Texas Health Science Center
Oct 22, 2021

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection Trial in Paris (1: discontinuation of

Terminated
  • History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection
  • 1: discontinuation of RAS blocker therapy
  • 2: continuation of RAS blocker therapy
  • Paris, France
    Cardiologie, Groupe Hospitalier Pitié-Salpêtrière
Apr 8, 2021

Hypertension Trial in Beijing, Zoucheng, ShenZhen (Protocol initiate with A, Protocol initiate with C, Protocol initiate with D)

Recruiting
  • Hypertension
  • Protocol initiate with A
  • +2 more
  • Beijing, Henan, China
  • +2 more
Apr 14, 2021

Hemophilia A Trial in Atlanta (aPCC-emicizumab, FEIBA, rFVIIa)

Not yet recruiting
  • Hemophilia A
  • Atlanta, Georgia
  • +1 more
Jan 5, 2023

ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and

Completed
  • COVID-19
    • Pozzilli, Italy
      IRCCS Neuromed, Department of Epidemiology and Prevention
    Sep 14, 2020

    Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)

    Recruiting
    • Chagas Cardiomyopathy
    • Sacubitril / Valsartan Oral Tablet [Entresto]
    • Enalapril
    • São Paulo, Brazil
      Heart Institute (Incor) University of Sao Paulo
    May 6, 2021

    Cardiovascular Disease, Chronic Kidney Disease Trial in Madison (angiotensin converting enzyme inhibitor, lisinopril)

    Completed
    • Cardiovascular Disease
    • Chronic Kidney Disease
    • Madison, Wisconsin
      University of Wisconsin-Madison Hospitals and Clinics
    Oct 8, 2020

    Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

    Recruiting
    • Diabetes Mellitus
    • Cardiovascular Diseases
    • Renin-angiotensin-aldosterone system inhibitors
    • +2 more
    • Singapore, Singapore
      Singapore General Hospital (SGH)
    Apr 28, 2021

    Hydrochlorothiazide and Risk of Skin Cancer

    Completed
    • Non-melanoma Skin Cancer
    • +2 more
    • Montreal, Quebec, Canada
      Centre for Clinical Epidemiology, Lady Davis Institute, Jewish G
    Mar 8, 2021

    Hypertension Trial in Thessaloniki, London (Anti-hypertensive Medication -)

    Completed
    • Hypertension
    • Anti-hypertensive Medication -
    • Thessaloniki, Greece
    • +1 more
    Mar 5, 2021

    Severe Hemophilia A, Moderate Hemophilia A Trial in Worldwide (Emicizumab)

    Recruiting
    • Severe Hemophilia A
    • Moderate Hemophilia A
    • Los Angeles, California
    • +10 more
    Aug 12, 2022

    CHF Trial (Beta-blockers including Carvedilol, ACE inhibitors)

    Completed
    • Heart Failure, Congestive
    • Beta-blockers including Carvedilol
    • ACE inhibitors
    • (no location specified)
    Nov 20, 2020

    Left Ventricular Hypertrophy, Hypertension Trial in Italy (ACE inhibitor Ramipril, non-RAS inhibitor antihypertensive therapy)

    Completed
    • Left Ventricular Hypertrophy
    • Hypertension
    • ACE inhibitor Ramipril
    • non-RAS inhibitor antihypertensive therapy
    • Ponte San Pietro, Bergamo, Italy
    • +28 more
    Jan 8, 2021

    Diabetic Nephropathy Type 2, Microalbuminuria Due to Type 2 Diabetes Trial in Bani Suwayf (Tritace (Ramipril 10 mg))

    Unknown status
    • Diabetic Nephropathy Type 2
    • Microalbuminuria Due to Type 2 Diabetes Mellitus
    • Tritace (Ramipril 10 mg)
    • Banī Suwayf, Egypt
      Faculty of Medicine,Beni-Suef University
    Jan 14, 2020

    COVID-19 Trial in Philadelphia (Discontinuation of ARB/ACEI, Continuation of ARB/ACEI)

    Completed
    • COVID-19
    • Discontinuation of ARB/ACEI
    • Continuation of ARB/ACEI
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Apr 7, 2021

    Angiotensin Converting Enzyme Inhibitors and Incident

    Unknown status
    • Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom
    • ACE inhibitor
    • (no location specified)
    Nov 11, 2020